The prognosis for patients with hormone sensitive cancers varies widely based on factors such as cancer type, stage at diagnosis, and response to treatment. Generally, hormone receptor-positive cancers tend to have a better prognosis compared to hormone receptor-negative cancers, as they can be treated with hormonal therapies.
